Lyn Rees Acquires 1,000,000 Shares of Yourgene Health Plc (LON:YGEN) Stock

Yourgene Health Plc (LON:YGENGet Rating) insider Lyn Rees bought 1,000,000 shares of Yourgene Health stock in a transaction dated Wednesday, May 11th. The stock was acquired at an average cost of GBX 7 ($0.09) per share, with a total value of £70,000 ($86,302.55).

Shares of LON:YGEN opened at GBX 7.25 ($0.09) on Friday. The company has a 50-day simple moving average of GBX 8.36 and a 200-day simple moving average of GBX 10.25. Yourgene Health Plc has a one year low of GBX 7 ($0.09) and a one year high of GBX 17.30 ($0.21). The company has a debt-to-equity ratio of 15.54, a quick ratio of 1.34 and a current ratio of 1.82. The stock has a market capitalization of £52.47 million and a price-to-earnings ratio of -5.18.

About Yourgene Health (Get Rating)

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome and other genetic disorders in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products.

Featured Stories

Receive News & Ratings for Yourgene Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yourgene Health and related companies with MarketBeat.com's FREE daily email newsletter.